A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
NCT ID: NCT05244915
Last Updated: 2025-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
73 participants
INTERVENTIONAL
2021-12-07
2023-08-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices
NCT03746314
Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer
NCT02531464
Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers
NCT06505122
Family Caregivers in Underserved Populations Providing Complex Cancer Care
NCT05213078
A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy
NCT01915056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Participants will receive a geriatric assessment which consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on participant responses, tailored recommendations will be provided.
Experimental (Delphi Surveys)
The Delphi method, a process used to arrive at a group opinion or decision by surveying a panel of experts, will be used with experts in geriatric oncology to develop a supportive care management intervention for older caregivers of older adults with cancer.
Experimental (Focus Groups)
Focus group qualitative interviews will be conducted with key stakeholders consisting of older adults with cancer and their caregivers.
Qualitative interviews
Qualitative interviews will be conducted with older caregivers of older adults with cancer to inquire about their experience with caregiving and unmet supportive care needs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental (Delphi Surveys)
The Delphi method, a process used to arrive at a group opinion or decision by surveying a panel of experts, will be used with experts in geriatric oncology to develop a supportive care management intervention for older caregivers of older adults with cancer.
Experimental (Focus Groups)
Focus group qualitative interviews will be conducted with key stakeholders consisting of older adults with cancer and their caregivers.
Qualitative interviews
Qualitative interviews will be conducted with older caregivers of older adults with cancer to inquire about their experience with caregiving and unmet supportive care needs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a diagnosis of solid tumor malignancy or lymphoma, any stage
* Patients who have initiated a new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy) OR are being considered for new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy).
* Patients and caregivers must be able to provide informed consent, or if it is determined that they do not have decision-making capacity, a patient-designated health care proxy must sign consent per institutional University of Rochester and Research Subject Review Board policies on consent for incapacitated/decisionally impaired subjects.
* Caregivers enrolled in phase I
* Patient and caregiver have completed a GA
* Member of SCOREboard Community Advisory Board
* Aged 65 years or older
* Has been a family member, partner, friend or caregiver to an older adult with cancer
* Members of the Cancer and Aging Research Group
* Primary care physicians who care for older adults
Exclusion Criteria
* Patient and caregivers who do not have decision-making capacity (decisionally or cognitively impaired) AND do NOT have a previously designated health care proxy available to sign consent.
• Patient and caregiver have not completed a GA
• None
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sindhuja Kadambi
Senior Instructor - Department of Medicine , Hematology/Oncology (SMD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sindhuja Kadambi
Role: PRINCIPAL_INVESTIGATOR
Univ. of Rochester Wilmot Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCCS21067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.